Working… Menu

Doxycycline for Hereditary Hemorrhagic Telangiectasia (HHT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03397004
Recruitment Status : Recruiting
First Posted : January 11, 2018
Last Update Posted : October 22, 2020
Barrow Neurological Institute
Duke University
Feinstein Institute for Medical Research
University of Pittsburgh
Sunnybrook Health Sciences Centre
Information provided by (Responsible Party):
Unity Health Toronto

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021